Skip to main content
I

Ipca Laboratories Ltd. — Investor Relations & Filings

Ticker · IPCALAB ISIN · INE571A01038 LEI · 33580069PZ8ZQVCDBC38 BSE.NS Manufacturing
Filings indexed 722 across all filing types
Latest filing 2023-06-03 Regulatory Filings
Country IN India
Listing BSE.NS IPCALAB

About Ipca Laboratories Ltd.

https://www.ipca.com

Ipca Laboratories Ltd. is a vertically integrated entity focused on the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs) and finished dosage formulations. The company serves a global market, distributing products to over 120 countries. Its therapeutic portfolio covers rheumatology, antimalarials, cardiology, gastroenterology, pain management, and diabetology. Notably, it is a leading global producer of antimalarial agents such as Chloroquine and Hydroxychloroquine. Operations are supported by multiple manufacturing sites that adhere to international regulatory standards, alongside dedicated research and development centers. The company’s strategic emphasis on backward integration allows for optimized production processes and the delivery of high-quality medicinal solutions across diverse healthcare sectors.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings
2023-06-03 English
Copy of Newspaper Publication
Regulatory Filings
2023-06-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-05-30 English
Related Party Transactions
Regulatory Filings
2023-05-29 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-29 English
Financial Result Updates
Regulatory Filings
2023-05-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.